INFRASTRUCTURE
From early process development to dependable commercial supply, our manufacturing network is designed to bring complex molecules to market with control, flexibility and quality at every step.
Dedicated API manufacturing sites capable of handling complex multi-step synthesis
Scalable from process development through commercial-scale production
Specialized handling for potent compounds with appropriate containment
Both sterile and non-sterile API capabilities
COMPLIANCE
EU GMP Compliant
Quality systems aligned to European GMP expectations.
WHO-GMP Certified
Consistent standards for safe, reliable medicines.
ISO 9001:2015
A quality management system built for continual improvement.
ANVISA (Under process)
Manufacturing registration for the Brazilian market currently under process.
TGA Compliant
Prepared for highly regulated global supply chains.
REGULATORY
Metoprolol Succinate, Amlodipine, Carvedilol, Cyclosporine
Metoprolol, Naproxen, selected APIs
Multiple APIs with European compliance
Selected cardiovascular APIs
Metoprolol, Amlodipine
Naprosyn (ANDA approved 2025)
MANUFACTURING ENQUIRY
For API sourcing, regulatory filing queries, or manufacturing partnership discussions, our team is ready to assist.